Interest builds in a new synthetic lethality story
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
Ideaya and GSK join Novartis and Roche in the Werner helicase inhibitor race.
But Repare and Black Diamond still have rebuilding to do.